Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
Kalkine: ASX200 Shake-Up: Soul Patts-Brickworks $14B Merger to Reshape Investment & Property Landscape
Financial Stocks

Kalkine: ASX200 Shake-Up: Soul Patts-Brickworks $14B Merger to Reshape Investment & Property Landscape

Highlights,Soul Patts and Brickworks announce a major $14B merger,$550M capital raise fully underwritten to support deal,New entity to,retain,name Washington H. Soul Pattinson (SOL),In a significant reshaping of the Australian investment and property land...

Kalkine: Lanthanein (ASX:LNR) Sharpens Focus on Gascoyne Gold & Base Metals in ASX200 Exploration Strategy
Metal & Mining Stocks

Kalkine: Lanthanein (ASX:LNR) Sharpens Focus on Gascoyne Gold & Base Metals in ASX200 Exploration Strategy

Highlights,Strategic shift towards gold and base metals in WA,Exit from non-core,Koolya,and Lady Grey assets,Review of historic exploration data to guide new drilling,Lanthanein Resources (ASX:LNR) has refined its exploration focus in Western Australia, c...

Kalkine: James Hardie’s $3.5B Azek Deal Boost: Major Move Within ASX200 Landscape
Metal & Mining Stocks

Kalkine: James Hardie’s $3.5B Azek Deal Boost: Major Move Within ASX200 Landscape

Highlights,James Hardie secures $3.5B syndicated debt,Funds to back planned,Azek,acquisition,Reduction of earlier bridge commitments to $1.7B,James Hardie Industries (ASX:JHX) has locked in a major financial milestone with the successful syndication of US...

Kalkine: Opthea Board Shake-Up Amid Trial Setback and Workforce Cuts: Impact on ASX200 Landscape
Healthcare Stocks

Kalkine: Opthea Board Shake-Up Amid Trial Setback and Workforce Cuts: Impact on ASX200 Landscape

Highlights,Four,Opthea,directors exit after clinical trial setback,Company slashes workforce by 65% amid,restructuring,Trading,remains,suspended on ASX and Nasdaq,Biotech company,Opthea (ASX:OPT),is undergoing major changes after a significant clinical tr...

Kalkine: $14 Billion Merger of WHSP and Brickworks Set to Reshape ASX200 Landscape
Growth Stocks

Kalkine: $14 Billion Merger of WHSP and Brickworks Set to Reshape ASX200 Landscape

Highlights,Brickworks and WHSP set to merge under $14 billion deal,New entity to simplify structure and boost shareholder value,Scrip-for-scrip tax relief expected for eligible investors,Two of Australia's most established companies, Washington H. Soul Pa...

ASX200 Set to Nudge Higher as Investors Eye GDP Data and Global Cues
Market Updates

ASX200 Set to Nudge Higher as Investors Eye GDP Data and Global Cues

Highlights,ASX200 futures hint at a positive open,Nasdaq posts strongest monthly rally since 2023,Key economic data in focus this week,The Australian share market is poised for a mild uptick at the start of the week, with S&P/ASX200 futures rising by 8 po...

Unlocking Trillions: How Data Fuels China- Thailand Business Boom
PRNews

Unlocking Trillions: How Data Fuels China- Thailand Business Boom

SHENZHEN, China, June 2, 2025 /PRNewswire/ -- This is a news report from Shenzhen Media Group: "When there's a big volume of products from China, it also helps the Thai economy because peop...

  • June 02, 2025 10:30 AM AEST
  • Cision
Kalkine: Perpetual’s Refinancing Boosts Outlook as ASX200 Firm Trims Debt Forecast
Financial Stocks

Kalkine: Perpetual’s Refinancing Boosts Outlook as ASX200 Firm Trims Debt Forecast

Highlights,Perpetual trims gross debt guidance for FY2025,New debt terms extend maturities to 2027,Positive signal from ASX dividend stock with strong capital management,Perpetual Limited (ASX:PPT) has made a strategic move to strengthen its financial pos...

Kalkine: Opthea Board Shake-Up: Director Exodus After Clinical Trial Failure Hits ASX200 Biotech (ASX:OPT)
Healthcare Stocks

Kalkine: Opthea Board Shake-Up: Director Exodus After Clinical Trial Failure Hits ASX200 Biotech (ASX:OPT)

Highlights,Four directors resign from,Opthea,amid clinical trial failure,OPT-302 trial setbacks raise solvency concerns,Ongoing talks continue with primary funders,In a major development impacting the Australian biotech landscape, Opthea Ltd (ASX:OPT) has...

Kalkine: Lithium Universe Ramps Up Bécancour Refinery Plans Amid Strategic Supply Talks
Metal & Mining Stocks

Kalkine: Lithium Universe Ramps Up Bécancour Refinery Plans Amid Strategic Supply Talks

Highlights,LU7 progresses long-term spodumene supply discussions,Targeting 140,000,tpa,lithium refinery capacity by 2030,Plans to,retain,full control of lithium carbonate output,Lithium Universe Ltd (ASX:LU7) is moving steadily toward becoming a key playe...

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.